NCT05521217

Brief Summary

The primary aim of the study was to measure the intra-rater and inter-rater reliability of MyotonPRO in measuring postural muscle tone and mechanical properties in individuals with spinal muscular atrophy (SMA). The secondary aim is to question the existence of a relationship between the functional levels of individuals with SMA and their muscle tone and biomechanical properties. It is assumed that the outputs to be obtained from this research will form the norm data for moyotonometer evaluation in children with SMA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 26, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 27, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 30, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2022

Completed
Last Updated

October 25, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

August 27, 2022

Last Update Submit

October 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Biomechanical and Viscoelastic Properties

    The biomechanical and viscoelastic properties of the plantar fascia will be measured with MyotonPRO device. The MyotonPRO (Tallin, Estonia) is a portable hand-held myotonometer. This device is non-invasive and provides a quantitative assessment of a muscle's viscoelastic properties. These properties are characterized by different parameters such as tone, elasticity, and stiffness. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle or facia. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.

    Day 1.

Study Arms (2)

Children with Spinal Muscular Atrophy

The patients were included if they were between 0 to 4 yeats, with a diagnosis of Spinal Muscular Atrophy.

Diagnostic Test: MyotonPRO

Healthy children

The healthy age-matched control group was included.

Diagnostic Test: MyotonPRO

Interventions

MyotonPRODIAGNOSTIC_TEST

Evaluation of biomechanics and viscoelastic properties of posture muscle in children with Spinal Muscular Atrophy. The biomechanical and viscoelastic properties of the posture muscle in children with Spinal Muscular Atrophy. will be measured with the MyotonPRO device.

Children with Spinal Muscular AtrophyHealthy children

Eligibility Criteria

Age1 Month - 4 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study was to be conducted with children with a diagnosis of Spinal Muscular Atrophy (SMA) followed in the Pediatric Chest Diseases Outpatient Clinic at Bağcılar Medipol Mega University Hospital and Istanbul Medipol Hospital, and with their families meeting the inclusion criteria of the study.

You may qualify if:

  • Between 0-4 years old
  • Diagnosed with spinal muscular atrophy (SMA)
  • Children who continue their medical treatment at home and are not in intensive care
  • Children of families who agreed to participate in the study and approved the informed consent form.

You may not qualify if:

  • Children of families who disagreed to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Seval Kutlutürk Yıkılmaz

Istanbul, Kavacık, 34810, Turkey (Türkiye)

Location

Seval Kutlutürk Yıkılmaz

Istanbul, 34810, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscle HypotoniaMuscular Atrophy, Spinal

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesNeuromuscular Diseases

Study Officials

  • Seval Kutlutürk Yıkılmaz

    Medipol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2022

First Posted

August 30, 2022

Study Start

August 26, 2022

Primary Completion

October 15, 2022

Study Completion

October 15, 2022

Last Updated

October 25, 2022

Record last verified: 2022-08

Locations